Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATNM Actinium Pharmaceuticals, Inc.

交易中 07-15 11:53:47 EDT

1.59

+0.02

+1.34%

最高1.59	最低1.52	成交量5.00万
今开1.55	昨收1.57	日振幅4.53%
总市值4,947万	流通市值4,922万	总股本3,120万
成交额7.78万	换手率0.16%	流通股本3,104万
市净率1.93	ROE-130.87%	每股收益-1.47
52周最高8.64	52周最低1.03	市盈率-1.08
股息0.00	股息收益率0.00	ROA-39.14%

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals, Inc.","latestPrice":1.5859,"timestamp":1752594668346,"preClose":1.565,"halted":0,"volume":50044,"delay":0,"floatShares":31037749,"shares":31195891,"eps":-1.472972,"marketStatus":"交易中","change":0.0209,"latestTime":"07-15 11:53:44 EDT","open":1.5505,"high":1.5859,"low":1.515,"amount":77798.7977476,"amplitude":0.045304,"askPrice":1.59,"askSize":200,"bidPrice":1.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.472972,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.565,"preHourTrading":{"tag":"盘前","latestPrice":1.55,"preClose":1.565,"latestTime":"09:04 EDT","volume":64,"amount":99.2199936,"timestamp":1752584654077},"postHourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.57,"latestTime":"18:18 EDT","volume":10,"amount":15.55,"timestamp":1752531481949},"volumeRatio":0.636633,"impliedVol":1.1872,"impliedVolPercentile":0.912},"requestUrl":"/m/hq/s/ATNM","defaultTab":"news","newsList":[{"id":"2550659555","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659555?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:58","pubTimestamp":1752073127,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时58分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.59%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1161.25%、715.12%、534.63%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、64.08%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225847979fc9ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225847979fc9ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2548355816","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548355816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548355816?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:27","pubTimestamp":1751470079,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时27分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速上涨5.19%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1942.41%、1324.74%、721.79%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为1145.92%、393.59%、111.57%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702232759953417d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702232759953417d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2546726619","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大跌5.56%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726619?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:01","pubTimestamp":1751050899,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时01分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速跳水5.56%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Eyenovia, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、天境生物涨幅较大，Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为237.74%、165.55%、131.61%，振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation，振幅分别为105.57%、74.75%、64.91%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280301399791b890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280301399791b890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2546731567","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546731567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546731567?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:56","pubTimestamp":1750946194,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时56分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速下挫5.16%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Vor Biopharma Inc.较为活跃，换手率分别为857.49%、209.16%、76.67%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为91.63%、40.05%、23.02%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626215635952cbfc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626215635952cbfc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2545744526","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 临近午盘快速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545744526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545744526?lang=zh_cn&edition=full","pubTime":"2025-06-23 23:45","pubTimestamp":1750693541,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日23时45分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速上涨5.33%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2459.29%、2014.52%、712.86%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623234542952837a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623234542952837a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2544926990","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 临近收盘股价大跌5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544926990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544926990?lang=zh_cn&edition=full","pubTime":"2025-06-18 03:46","pubTimestamp":1750189616,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日03时46分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.23%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为1.62%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Acurx Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为10924.26%、4783.98%、2468.81%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Processa Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为450.48%、260.06%、242.28%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618034657a70ef237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618034657a70ef237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2542754346","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌6.02%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542754346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542754346?lang=zh_cn&edition=full","pubTime":"2025-06-12 23:14","pubTimestamp":1749741248,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日23时14分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下挫6.02%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃，换手率分别为2159.15%、664.54%、193.55%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma, Inc.，振幅分别为169.83%、92.64%、87.67%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612231408a4a57069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612231408a4a57069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2542533768","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘大幅跳水5.64%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542533768?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:04","pubTimestamp":1749650684,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时04分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速跳水5.64%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Kazia Therapeutics Limited、Vaxart, Inc. - Common Stock、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为6806.90%、2129.00%、164.23%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Liminatus Pharma Inc C/Wts 30/04/2030 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为56.33%、51.40%、50.85%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220445977b0f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220445977b0f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2542332266","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 临近收盘股价大涨5.19%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542332266?lang=zh_cn&edition=full","pubTime":"2025-06-10 03:36","pubTimestamp":1749497794,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日03时36分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.19%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.61%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为17590.25%、3136.46%、3135.54%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Citius Pharmaceuticals, Inc.，振幅分别为673.58%、582.93%、175.09%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610033635a4a0cdd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610033635a4a0cdd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2541307869","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.03%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541307869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541307869?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:14","pubTimestamp":1749219277,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时14分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速拉升5.03%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Prime Medicine, Inc.、Klotho Neurosciences, Inc.涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为2120.47%、687.86%、82.86%，振幅较大的相关个股有Eyenovia, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tango Therapeutics, Inc.，振幅分别为36.94%、34.76%、32.22%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606221437a49d0774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606221437a49d0774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2540976667","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540976667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540976667?lang=zh_cn&edition=full","pubTime":"2025-06-03 00:47","pubTimestamp":1748882826,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日00时47分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.19%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为2.12%。其相关个股中，Lyra Therapeutics, Inc.、Vera Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Nucana Plc较为活跃，换手率分别为1721.29%、1187.70%、435.46%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为269.79%、111.83%、80.62%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603004706976ea348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603004706976ea348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2537159388","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537159388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537159388?lang=zh_cn&edition=full","pubTime":"2025-05-24 01:46","pubTimestamp":1748022391,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日01时46分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下跌5.29%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为4366.72%、2292.35%、1098.01%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、101.08%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524014632aa2c98a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524014632aa2c98a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2537993632","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大跌6.96%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537993632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537993632?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:32","pubTimestamp":1747834358,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时32分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下跌6.96%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Polyrizon Ltd.、Nucana Plc、Protagenic Therapeutics, Inc.较为活跃，换手率分别为6594.68%、424.73%、43.93%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Revolution Medicines Inc C/Wts 17/12/2026 、Relmada Therapeutics, Inc.，振幅分别为20.41%、18.25%、14.72%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213250a6e7845e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213250a6e7845e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2536593637","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速上涨5.99%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536593637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536593637?lang=zh_cn&edition=full","pubTime":"2025-05-20 03:48","pubTimestamp":1747684121,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日03时48分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅上涨5.99%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Protagenic Therapeutics, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为16265.93%、10927.64%、2844.33%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为894.34%、262.71%、138.78%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520034841975ea26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520034841975ea26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2536951342","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大涨5.24%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536951342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536951342?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:45","pubTimestamp":1747421128,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时45分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.24%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5244.65%、3738.69%、1696.67%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024528a6e1fabe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024528a6e1fabe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2535876179","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535876179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535876179?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:52","pubTimestamp":1747327972,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时52分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅上涨5.47%。截至发稿，该股报1.54美元/股，成交量8.6067万股，换手率0.28%，振幅8.90%。其相关个股中，Nucana Plc、Abpro Holdings, Inc、Scpharmaceuticals Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为12350.50%、4897.89%、311.83%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Renovaro Inc.、Nucana Plc，振幅分别为76.92%、68.18%、63.87%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051600525294f81b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051600525294f81b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2535008754","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速下跌5.26%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535008754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535008754?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:48","pubTimestamp":1747241286,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日00时48分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.26%。截至发稿，该股报1.44美元/股，成交量6.6906万股，换手率0.21%，振幅5.59%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、蓝鸟生物涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为4344.73%、4335.02%、1567.17%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.，振幅分别为339.54%、201.95%、135.53%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515004807a47e6b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515004807a47e6b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2533630153","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533630153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533630153?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:48","pubTimestamp":1746539306,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时48分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅跳水5.00%。截至发稿，该股报1.43美元/股，成交量2.1101万股，换手率0.07%，振幅5.33%。其相关个股中，Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为2624.54%、912.85%、245.33%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为84.51%、38.46%、27.02%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621482694ee1104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621482694ee1104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2533053989","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533053989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533053989?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:27","pubTimestamp":1746455231,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日22时27分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速下跌5.10%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nucana Plc涨幅较大，Nucana Plc、Scisparc Ltd.、Polyrizon Ltd.较为活跃，换手率分别为844.95%、575.78%、68.47%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Scisparc Ltd.、Nucana Plc，振幅分别为113.27%、47.40%、46.57%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505222711a6d3eab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505222711a6d3eab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2531183055","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.59%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531183055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531183055?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:58","pubTimestamp":1746021537,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时58分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速下跌5.59%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为135.98%、24.13%、12.38%，振幅较大的相关个股有Nutriband Inc.、Immunic, Inc.、Polypid Ltd.，振幅分别为29.23%、19.53%、18.89%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc 是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发放射疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215858974ba781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215858974ba781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actiniumpharma.com","stockEarnings":[{"period":"1week","weight":0.1056},{"period":"1month","weight":0.0537},{"period":"3month","weight":0.246},{"period":"6month","weight":0.2869},{"period":"1year","weight":-0.7893},{"period":"ytd","weight":0.246}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actinium Pharmaceuticals, Inc.于1997年10月6日在内华达州注册成立。该公司曾是一家空壳公司，在市场上与合适的经营公司合并。该公司现在是一家生物制药公司，专注于抗癌药物的540亿美元的市场。该公司最先进的产品是Actimab -A ，含有AC-225抗体药物结构，目前在急性髓系白血病（AML）和Iomab-B——一种包含iodine131的抗体药物结构进行人体临床试验，用于造血干细胞移植时使用。该公司目前正在设计并申请一项造血干细胞移植的试验，主要针对老年患者难治的复发性急性髓系白血病。该公司正在利用其在放射免疫治疗领域的专业知识开发治疗癌症的药物。此外， AC-225为基础的药物开发依赖于专利的α粒子免疫治疗技术（ APIT ）平台，这是与Memorial Sloan Kettering癌症中心合作开发的技术，该中心的间接附属公司Actinium Holdings有限责任公司是制药公司的大股东。APIT技术与单克隆抗体结合时非常有效，但相对安全的α粒子会发射放射性同位素，尤其是锕225和铋213 ，最终药物结构的设计是专门针对并且杀死癌细胞，同时尽量减少副作用。该公司拟开发不同类型的癌症治疗产品，从与大型制药公司的合作和直接在专业市场销售其产品获得收益。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.038283},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009732},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.04316},{"month":4,"riseRate":0.25,"avgChangeRate":-0.045947},{"month":5,"riseRate":0.75,"avgChangeRate":0.07838},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.028282},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.018869},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.113388},{"month":9,"riseRate":0.454545,"avgChangeRate":0.034022},{"month":10,"riseRate":0.545455,"avgChangeRate":0.061839},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.052518},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.061471}],"exchange":"AMEX","name":"Actinium Pharmaceuticals, Inc.","nameEN":"Actinium Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actinium Pharmaceuticals, Inc.,ATNM,Actinium Pharmaceuticals, Inc.股票,Actinium Pharmaceuticals, Inc.股票老虎,Actinium Pharmaceuticals, Inc.股票老虎国际,Actinium Pharmaceuticals, Inc.行情,Actinium Pharmaceuticals, Inc.股票行情,Actinium Pharmaceuticals, Inc.股价,Actinium Pharmaceuticals, Inc.股市,Actinium Pharmaceuticals, Inc.股票价格,Actinium Pharmaceuticals, Inc.股票交易,Actinium Pharmaceuticals, Inc.股票购买,Actinium Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况